包装 | 价格(元) |
100mg | 电议 |
250mg | 电议 |
500mg | 电议 |
生物活性 | VEGFR-2/DHFR-IN-1 (compound 8b) is an inhibitor ofVEGFR-2andDHFRwithIC50s of 0.384 and 7.881 μM, respectively. VEGFR-2/DHFR-IN-1 shows good antibacterial activities againstEscherichia coli,Streptococcus faecalis,Salmonella enterica,MSSAandMRSAwithMICvalues of 16, 16, 16, 8, and 16 μg/mL, respectively. VEGFR-2/DHFR-IN-1 exhibits good cytotoxic activities against C26, HepG2, and MCF7cancercell lines withIC50values of 2.97-7.12 μM. VEGFR-2/DHFR-IN-1 can be used for the research ofcancer[1]. | ||||||||
IC50& Target |
| ||||||||
体外研究 (In Vitro) | VEGFR-2/DHFR-IN-1 (2-1024 μg/mL; 18-72 h) shows antibacterial and antifungal activities with MIC values of 16, 64, 16, 16, 8, 16, 64 and 256 μg/mL forEscherichia coli,Pseudomonas aeruginosa,Streptococcus faecalis,Salmonella enterica,MSSA,MRSA,Candida albicansandAspergillus niger, respectively[1].VEGFR-2/DHFR-IN-1 (0.5-100 μM; 48 h) exhibits anticancer activities[1].VEGFR-2/DHFR-IN-1 (0-100 μM; 30 min) shows DHFR and VEGFR-2 inhibitory activities with IC50s of 7.881 and 0.384 μM, respectively[1]. Cell Cytotoxicity Assay[1]
| ||||||||
分子量 | 371.81 | ||||||||
Formula | C20H18ClNO4 | ||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |